NCT01472250

A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 498 (actual)
• Sponsor: Peking University · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-center, prospective and observational clinical study. Eligible patients will accept generalized chemotherapy according to the investigator's assessment. Information related to the treatment, including medication, disease condition, expenses, etc. will be periodically collected. Follow-up at 2-month intervals will be periodically performed to continually collect information about the disease progression, subsequent treatment and survival until death or completion of the study. Recruited patients will fill out questionnaires about quality of life before initiation of treatment, at Cycle 3 and completion of first-line treatment.

Conditions

• Advanced Gastric Cancer

Interventions

Type	Name	Description
DRUG	Clinical chemo-drugs	Clinical drugs will be selected by the investigator according to recommendations in Chinese and foreign guidelines and depending on clinical experience and the patient's individual conditions, including but not limited to the drugs listed below: Platinum products: oxaliplatin, cisplatin Fluorouracil products: 5-fluorouracil, capecitabine, TS-1 Taxanes: paclitaxel, docetaxel

Timeline

• Start date: 2011-11-01
• Primary completion: 2016-07-01
• Completion: 2016-07-01
• First posted: 2011-11-16
• Last updated: 2017-05-09

Locations

1 site across 1 country: China